Cardinal Health, Inc. (NYSE: CAH) had its price target lowered by analysts at Argus from $120.00 to $115.00. They now have a "buy" rating on the stock.
LowReport
Cardinal Health, Inc. (NYSE: CAH) had its price target lowered by analysts at Argus from $120.00 to $115.00. They now have a "buy" rating on the stock.
Global Healthcare Distribution Strategic Industry Report 2024-2030: Substandard and Counterfeit Drugs, an Urgent Challenge in the Supply Chain that Needs to be Addressed [Yahoo! Finance]
LowReport
Global Healthcare Distribution Strategic Industry Report 2024-2030: Substandard and Counterfeit Drugs, an Urgent Challenge in the Supply Chain that Needs to be Addressed [Yahoo! Finance]
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:
Don’t Miss Out On The Next BIG Stock Move
"Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ blog email newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our blog below: